Table 2.
Characteristics of adult HIV-infected patients enrolled on ART care in Southwest Ethiopia from 2003 to 2015, Jimma, Ethiopia
| Variable | n=4900, n (%) |
| Age in years | |
| 15 to ≤25 | 711 (14.5) |
| 25 to ≤50 | 3937 (80.3) |
| 50+ | 252 (5.2) |
| Median (range) age in years | 30 (15–81) |
| ART follow-up time in months, median (range) | 49 (0–137) |
| Estimated survival time in months, median (95% CI) | 121.9 (120.3 to 123.5) |
| Sex | |
| Male | 1971 (40.2) |
| Female | 2929 (59.8) |
| Marital status* | |
| Never married | 897 (20.9) |
| Married | 2094 (48.7) |
| Separated/divorced/widowed | 1311 (30.5) |
| Education* | |
| No education | 945 (21.9) |
| Primary | 1687 (39.1) |
| Secondary and above | 1685 (39) |
| Religion* | |
| Muslim | 1402 (32.6) |
| Christian† | 2893 (67.4) |
| Baseline WHO classification* | |
| 1 or 2 | 1355 (45.7) |
| 3 or 4 | 1608 (54.3) |
| Baseline CD4 count (cells/mm3)* | |
| <200 | 3275 (73.6) |
| ≥200 | 1174 (26.4) |
| Median (range) | 156 (0–1313) |
| Hx of TB/HIV coinfection* | |
| No | 3533 (72.1) |
| Yes | 1367 (27.9) |
| ARV adherence* | |
| Good | 4064 (82.9) |
| Fair or poor | 836 (17.1) |
| Cotrimoxazole adherence* | |
| Good | 4119 (94.4) |
| Fair or poor | 762 (15.6) |
| Hx of HIV testing* | |
| Yes | 2860 (58.4) |
| No | 2040 (41.6) |
| ART shift* | |
| No | 3190 (99.1) |
| Yes | 29 (0.9) |
| Baseline functional status* | |
| Work or ambulatory | 3064 (68.1) |
| Bedridden | 1437 (31.9) |
| Timing to HIV diagnosis | |
| Early | 894 (33.3) |
| Late | 1788 (66.7) |
| Clinical failure* | |
| No | 2261 (80.5) |
| Yes | 546 (19.5) |
| Immunological failure* | |
| No | 3164 (80.3) |
| Yes | 775 (19.7) |
| Treatment failure* | |
| No | 3239 (72.5) |
| Yes | 1231 (27.5) |
*Only valid percentage is calculated.
†Orthodox, catholic, protestant.
ART/ARV, antiretroviral therapy; CD4, cluster for differentiation 4; TB, tuberculosis.